Blog | HemaCare

CD34+ and CD34+CD133+ Stem Cell Levels Predict Cardiovascular Outcome in Patients With Type 2 Diabetes

Feb 20, 2017 8:00:54 AM / by Stacy Matthews Branch, DVM, PhD posted in bioreasearch, cd 34 stem cells, CD133+, research, stem cell research, Stem Cells


Cardiovascular diseases are a leading cause of death worldwide. There are various risk factors for cardiovascular disease such as obesity, physical inactivity, smoking, and diabetes. The risk of cardiovascular disease and stroke in patients with type 2 diabetes is more than twice that of people without diabetes.

Read More

Can We Eliminate Cancer Stem Cells Along with the Tumor?

May 18, 2015 1:00:55 PM / by Daisy posted in epitope, glioblastoma, Cancer Immunology, cancer immunotherapy, cancer stem cells, CD133+, dendritic cell vaccine, Independent validation, research, Stem Cells


Scientists use PBMCs from HemaCare to design experiments in cancer immunotherapy. Cancer stem cells become a target!

Read More

Stem Cells for Manfacturing Transfusion Medicine Supplies

Sep 29, 2014 1:00:45 PM / by Daisy posted in CD133+, CD34, megakaryocytes, myeloid, Platelets, research


Growing platelets from hematopoietic stem cells may be a small step in science, but a leap in transfusion medicine

Read More

Subscribe Here!

Posts by Topic

see all

Recent Posts